BRIEF REPORT Development and Implementation of a Wheelchair Outcomes Registry Mark R. Schmeler, PhD, OTR/L, ATP, a Richard M. Schein, PhD, MPH, a Andi Saptono, PhD, b Vince J. Schiappa, MS a From the a Department of Rehabilitation Science and Technology, University of Pittsburgh, Pittsburgh, Pennsylvania; and b Department of Health Information Management, University of Pittsburgh, Pittsburgh, Pennsylvania, the United States. Abstract Objective: To describe the development of a patient registry related to wheeled mobility and seating (WMS) device interventions to accumulate large datasets for clinical quality assurance and research purposes. Design: Accepted guidelines for registry development were applied and anchored around the Functional Mobility Assessment (FMA) questionnaire and a uniform dataset (UDS). Setting: The FMA and UDS were developed under a corporate research agreement between clinical researchers and commercial providers. The questionnaires are administered in rehabilitation clinics to patients at the time of assessment for new device interventions (baseline) and readministered by telephone or other remote strategies periodically thereafter (follow-up). Participants: The FMA and UDS can be administered to any patient with a mobility impairment in need of a WMS device. Interventions: WMS interventions include manual wheelchairs, power wheelchairs, scooters, seating, and other accessories. Main Outcome Measures: The FMA is a validated 10-item patient-centered outcome measure that investigates satisfaction in performing common mobility-related activities of daily living. The UDS includes variables related to age, diagnosis, and type of device used, as well as health, participation, and environmental factors. Results: Currently there are over 1500 complete FMA and UDS cases at baseline and more than 600 follow-up datasets from 45 providers nationwide. Feedback indicates use of the FMA and UDS does not add burden to the clinical routine. Conclusions: A registry in the field of WMS has been developed and shown to be feasible in a clinical setting. This has created an opportunity to collect large datasets to increase sample sizes for future analyses to more scientifically evaluate what types of WMS devices work best for what types of patients under varying circumstances to promote health and participation. Archives of Physical Medicine and Rehabilitation 2019;-:------- ª 2019 by the American Congress of Rehabilitation Medicine Studies estimate there are 3.6 million people with disabilities (PWD) aged 15 and over and not within institutions in the United States who use a wheeled mobility and seating (WMS) device including manual wheelchairs, power wheelchairs, and scooters while an additional 11.6 million individuals use a cane, crutches, or walker for mobility. 1 Reports indicate that properly provided WMS devices may reduce secondary health issues such as falls and pressure sores as well as increase quality of life. 2 Access to properly prescribed equipment can be difficult. Policymakers such as the Centers for Medicare & Medicaid Ser- vices have developed more restrictive coverage policies and reduced fee schedules in response to Office of the Inspector General reports of concerns of waste, fraud, and abuse. 3 There are concerns that these policies are restricting access to devices by people who clinically need them. However, it is difficult for practitioners, advocates, and other stakeholders to counter these policies when reviews of the literature suggest the strength of scientific evidence on the effectiveness of WMS interventions or service delivery models to support proper provision is low. 4 Presented to the International Seating Symposium, March 2-4, 2017, Nashville, TN; the Heartland Conference, June 13-15, 2017, Waterloo, IA; and Rehabilitation Engineering and As- sistive Technology Society of North America, June 28-30, 2017, New Orleans, LA. Supported by the National Institute on Disability, Independent Living, and Rehabilitation Research (grant no. H133E990001) and the Van G. Miller Group (contract no. 0050185). Disclosures: Mark Schmeler receives a royalty through the University of Pittsburgh Office of Innovation. The other authors have nothing to disclose. 0003-9993/19/$36 - see front matter ª 2019 by the American Congress of Rehabilitation Medicine https://doi.org/10.1016/j.apmr.2019.03.007 Archives of Physical Medicine and Rehabilitation journal homepage: www.archives-pmr.org Archives of Physical Medicine and Rehabilitation 2019;-:-------